A partnership between
×
.jpg)
×
Admera Health and 10x Genomics have partnered to offer industry research teams complimentary single-cell sequencing services using the new Flex Apex Kit. Three winners. Three prize tiers. No cost to you.
Apply for complimentary single-cell sequencing services using the 10x Genomics Flex Apex Kit. Three prize tiers. No cost to winners.
Takes less than 10 minutes to complete the interest form.
×
Admera Health and 10x Genomics have partnered to give industry research teams direct access to the Flex Apex Kit workflow at no cost, to accelerate drug discovery, translational research, and commercial development.
Single-cell gene expression optimized for fixed and FFPE samples, ideal for precious clinical biobank material.
Kit reagents, library preparation, and sequencing, all in one program.
Designed for biotech, pharma, and CRO teams with active commercial research projects.
Admera Health is among the first certified service providers to offer Flex Apex on rat tissue, purpose-built for workflows in pharma and biotech.
All samples are processed at Admera Health's certified genomics facility with strict quality controls and dedicated scientific support throughout your project.
Admera Health empowers researchers to unlock the hidden complexities of cells with our advanced single-cell analysis solutions. We leverage our expertise in Next-Generation Sequencing (NGS) to offer single-cell insights with high throughput and accuracy to support data-driven results.
All samples are processed in a CLIA/CLEP-certified and CAP-accredited environment, ensuring the utmost quality. Committed to cutting-edge technology, Admera Health utilizes state-of-the-art platforms and tools for genomic sequencing and data interpretation.
Every prize includes the full Flex Apex workflow — reagents, library prep, and sequencing — delivered by Admera Health. All three prizes are drawn from a single 96-rxn Flex Apex Kit.
Applications are reviewed on a rolling basis. Submit early for the best chance of selection.
This program is specifically designed for commercial life science researchers. Please review eligibility carefully before applying.
Additional Information & Terms:
You will receive the full application document in your inbox within one business day.
This program is open to researchers employed by commercial life science organizations including biotech, pharma, and CRO companies. Teams working with rat FFPE tissue are also eligible. Academic institutions and non-profit organizations are not eligible for this program cycle.
The Flex Apex Kit is a single-cell gene expression solution from 10x Genomics optimized for fixed samples including FFPE and other preserved formats. This makes it particularly well-suited for precious clinical and biobanked material used in drug discovery and translational research.
Yes. Admera Health now supports rat FFPE tissue on the Flex Apex platform, making this grant one of the only fully sponsored single-cell opportunities available for groups working with rat samples. This capability was recently launched and is available to all grant applicants. Grant-eligible sample types include both human and rat FFPE tissue.
All prizes include the 10x Genomics Flex Apex 96-rxn Kit and associated reagents (provided by 10x Genomics), plus library preparation and sequencing performed by Admera Health at no cost to the winner. Winners are also invited to participate in a joint webinar to present their results.
If your project requires more samples than your awarded tier, you can upgrade to a larger run at a discounted rate. The only requirement is that all samples arrive together in a single shipment. Just flag it when you are notified as a winner and the Admera Health team will work through the options with you.
An internal review committee from Admera Health and 10x Genomics evaluates all eligible applications based on three criteria: research creativity, scientific impact, and innovation. Applications are reviewed on a rolling basis but all final decisions are made after the August 31 deadline.
All applicants will be notified of the outcome in September 2026. Non-winners will receive follow-up from the Admera Health team with information on standard Flex Apex service pricing and upcoming promotions. All applicants will also be invited to the joint webinar in Q4 2026 or Q1 2027.
Multiple individuals from the same company may apply separately, subject to the one-entry-per-person rule. Each application must represent a distinct project and be submitted by a different individual.
Winners are strongly encouraged to participate in the joint webinar as it is a great opportunity to present your research findings and gain visibility within the single-cell genomics community.